GENE ONLINE|News &
Opinion
Blog

2021-04-16| SpecialTechnology

T Cells and Cancer: Uncovering the Unknowns

by Daniel Ojeda
Share To
T cells are potent cancer-killing immune cells but cancers have developed several ways to escape them. In recent years, immunotherapies such as CAR T cells and immune checkpoint inhibitors have reactivated the T cells to be effective against cancers. Understanding the interactions between cancer cells and T cells could help us develop novel therapeutics. Here we present key takeaways from the virtual AACR conference presentations that focussed on T Cells in Cancer.

GO Prime with only $1.49 now

LATEST
Pioneers of AI Win Nobel Prize in Physics for Training Neural Networks with Physics
2024-10-09
2024 Nobel Prize in Medicine: Discovering the Secrets of microRNA in Gene Regulation
2024-10-08
Sciwind Biosciences Announces Oral Presentation on Oral GLP-2 Research Progress at the 32nd United European Gastroenterology Week (UEG Week 2024)
2024-10-07
Bio Japan 2024 and Medical Japan 2024 Unleashing Innovation in Biopharmaceuticals and Healthcare Technologies
2024-10-07
Starboard Value Takes $1 Billion Stake in Pfizer, Eyes Major Overhaul
2024-10-07
Generative AI Makes its Debut in Smart Healthcare with NVIDIA Experts at the Helm
2024-10-04
How TCELS is Moving Thailand’s Biotech Industries From Local to Global
2024-10-04
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
2024-10-28
BioFuture 2024
New York, U.S.A.
2024-10-30
AusBiotech 2024
Melbourne, Australia
2024-11-04
BIO-Europe 2024
Stockholm, Sweden
Scroll to Top